Follow us
GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
SNS
Latest Information
Read more
11/09/2023
Information
New stock price board in our “Investor Relations” page
11/08/2023
Information
GNI’s actual stance towards suspicious trading practices of our stock
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(ETUARY)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
IR News
Message
Stock Quote
